May 19, 2015 | The Israeli medical devices company Medigus filed a prospectus with the US Securities and Exchange Commission (SEC) to issue its shares as American depository receipts. Medigus currently has a market-cap of NIS 120 million ($31.1 million) and has planned for some time to trade their securities in the US. The largest shareholder in Medigus is OrbiMed Advisors. Medigus was founded in 2000 and develops innovative endoscopic devices.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments